Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Intrathecal DexmedetomidineAdductor Canal BlockAnalgesiaTotal Knee Arthroplasty
Interventions
DRUG

Intrathecal Dexmedetomidine

Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml saline 0.9% at the end of surgery

DRUG

Adductor Canal Block

Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 0.5ml saline 0.9% + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.

DRUG

Intrathecal Dexmedetomidine + Adductor Canal Block

Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.

Trial Locations (1)

33516

RECRUITING

Kafrelsheikh University, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER